ÂÜÀòÂÒÂ×

Karin Bless currently serves as the Head of Global Patient Safety Operations at Argenx, a position held since November 2022. Previously, Karin held senior leadership roles, including Senior Director of Global Safety Management at both IQVIA Biotech and Novella Clinical, overseeing global safety management services and participation in senior leadership teams. Karin's extensive experience in pharmacovigilance and safety includes positions at ICON Clinical Research, STADA Arzneimittel AG, and ICON GmbH, focusing on clinical trial safety, project governance, and regulatory compliance. Additionally, Karin has a background as a Holistic Medical Health Practitioner and Advanced Care Nurse, with substantial experience in intensive care and post-operative settings, alongside early career work as a tourist guide.